R&D Published on May 26, 2020 Researchers from a dozen countries, including a professor from Université Laval (QC), are jointly conducting a study on sleep disorders caused by the pandemic. Read more on Radio-Canada (Health)
R&D Published on May 25, 2020 A Quebec company, IMV Inc. announced encouraging results for its vaccine against COVID-19. They were tested on mice. Read more on La Presse
Medtech Published on May 25, 2020 UV-C germicide technology, of which SANUVOX Technologies (Montreal) has been a world leader for 25 years, has been at the forefront of the fight against coronavirus in France and Canada for the decontamination of N95 masks. Read more on News Wire
R&D Published on May 25, 2020 The University’s Institute for Research in Immunology and Cancer (IRIC) has received a $500,000 donation that will go to the Therapeutic Cancer Vaccine Fund and allow research teams to complete the final crucial steps leading to clinical trials of a cancer vaccine. Read more on News Wire
Business environment Published on May 20, 2020 With its many talents, academic institutions and companies in the life sciences and health technologies sector, Québec stands out in North America. As a sign of this success, investments are pouring in. Here are a few figures that explain why the province is well positioned in coronavirus research. Read more on La Presse
Business environment Published on May 20, 2020 “The key to overcoming the challenge is knowledge, and more specifically protecting our scientific knowledge locally,” says McCauley, President and CEO of adMare BioInnovations. In addition to contributing to everyone’s security, Quebec’s life sciences sector brings together all the elements that will enable it to become a powerful lever for revitalizing our economy. Here’s how. Read more on La Presse
Medtech Published on May 20, 2020 “We have research labs in Quebec and Montreal ready to lend a hand to support the public, hospitals and businesses in their battle against VIDOC-19,” says Dr. Sylvain Desrochers, a doctor and clinical biochemist. For more than 25 years, he has led the team at CIRION BioPharma Research, a leading Laval-based laboratory. Read more on La Presse
Biotech Published on May 20, 2020 Choosing people cured of COVID-19 to find the right antibody to neutralize the virus is the challenge that Immune Biosolutions has set itself. Its ultimate goal is to develop an immunotherapy against the coronavirus in Quebec. To achieve this goal, the Sherbrooke-based company sought the crucial collaboration of several Quebec organizations. Read more on La Presse
Manufacturing Published on May 20, 2020 The race against time to find a vaccine against COVID-19 involves the Laval (QC) SME GA International, which has gone into emergency mode to meet the demand for specialized labels from pharmaceutical companies and research laboratories around the world. Read more on La Presse